SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Convertible Notes Payable, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Convertible Notes Payable, Current of $600.00 thousand as of 2024-08-06, per its 10-Q filed 2024-09-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-02-26
- 2024-08-06: Convertible Notes Payable, Current $600.00K.
- 2024-06-30: Convertible Notes Payable, Current $826.24K.
- 2024-03-31: Convertible Notes Payable, Current $941.40K.
- 2023-12-31: Convertible Notes Payable, Current $596.00K; Convertible Notes Payable, Current as first filed $731.09K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2024-08-06 | $600.00K 10-Q · filed 2024-09-04 | |
| 2024-06-30 | $826.24K 10-Q · filed 2024-09-04 | |
| 2024-03-31 | $941.40K 10-Q/A · filed 2024-09-04 | |
| 2023-12-31 | $596.00K 10-K · filed 2025-02-26 | $731.09K 10-K · filed 2024-03-21 |
| 2023-09-30 | $597.21K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $390.71K 10-Q · filed 2023-08-14 | |
| 2018-06-04 | $120.25K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |